Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
In the next year, we will have the study to show whether it makes sense to give finerenone to protect the kidney in people with type 1 diabetes and CKD. Other trials of note include Remodel T1D and SUGARNSALT, but neither is sponsored by a drug company
Start with Part 1: Setting Realistic Weight Loss Expectations Nutrition Therapy for Side Effects GLP-1 therapy can be an immensely impactful class of medication for obesity treatment and improving metabolic healthbut it only works if you can tolerate it
A lack of investment from the pharmaceutical industry has also stalled research
Researchers studying heart health conditions are very interested in this BPC-157 nasal spray benefit
John Tomase John Tomase Published Mar 9, 2026 Months of rancor between Novo Nordisk and Hims & Hers came to an end Monday when the companies agreed to sell obesity drugs together
US$ 28.73
US$ 22.14
US$ 28.54
